Search

Michael Trettel

Examiner (ID: 10179)

Most Active Art Unit
3673
Art Unit(s)
3673, 3505, 3633, 3627, 3628, 3508
Total Applications
3400
Issued Applications
2898
Pending Applications
103
Abandoned Applications
400

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 3937675 [patent_doc_number] => 05872005 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Packaging cell lines for adeno-associated viral vectors' [patent_app_type] => 1 [patent_app_number] => 8/439586 [patent_app_country] => US [patent_app_date] => 1995-05-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 19 [patent_no_of_words] => 9243 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 22 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872005.pdf [firstpage_image] =>[orig_patent_app_number] => 439586 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/439586
Packaging cell lines for adeno-associated viral vectors May 11, 1995 Issued
Array ( [id] => 3847814 [patent_doc_number] => 05766901 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-06-16 [patent_title] => 'Apparatus and method for delivering a nucleotide into cell nuclei' [patent_app_type] => 1 [patent_app_number] => 8/434750 [patent_app_country] => US [patent_app_date] => 1995-05-04 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 15 [patent_no_of_words] => 3260 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/766/05766901.pdf [firstpage_image] =>[orig_patent_app_number] => 434750 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/434750
Apparatus and method for delivering a nucleotide into cell nuclei May 3, 1995 Issued
Array ( [id] => 3723167 [patent_doc_number] => 05681745 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-28 [patent_title] => 'Biotin-binding containment systems' [patent_app_type] => 1 [patent_app_number] => 8/432017 [patent_app_country] => US [patent_app_date] => 1995-05-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 6701 [patent_no_of_claims] => 52 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 17 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/681/05681745.pdf [firstpage_image] =>[orig_patent_app_number] => 432017 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/432017
Biotin-binding containment systems Apr 30, 1995 Issued
08/427348 METHODS FOR SCREENING EXPRESSION LIBRARIES Apr 23, 1995 Abandoned
Array ( [id] => 3695859 [patent_doc_number] => 05677139 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-10-14 [patent_title] => 'In vitro differentiation of CD34.sup.+ progenitor cells into T lymphocytes' [patent_app_type] => 1 [patent_app_number] => 8/426782 [patent_app_country] => US [patent_app_date] => 1995-04-21 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 10305 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 32 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/677/05677139.pdf [firstpage_image] =>[orig_patent_app_number] => 426782 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/426782
In vitro differentiation of CD34.sup.+ progenitor cells into T lymphocytes Apr 20, 1995 Issued
Array ( [id] => 3784841 [patent_doc_number] => 05736367 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-04-07 [patent_title] => 'Vectors and prokaryotes which autocatalytically delete antibiotic resistance' [patent_app_type] => 1 [patent_app_number] => 8/425380 [patent_app_country] => US [patent_app_date] => 1995-04-20 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 39 [patent_figures_cnt] => 42 [patent_no_of_words] => 9168 [patent_no_of_claims] => 14 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 15 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/736/05736367.pdf [firstpage_image] =>[orig_patent_app_number] => 425380 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/425380
Vectors and prokaryotes which autocatalytically delete antibiotic resistance Apr 19, 1995 Issued
08/424328 GENE DELIVERY FUSION PROTEINS Apr 16, 1995 Abandoned
Array ( [id] => 4002241 [patent_doc_number] => 06004810 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes' [patent_app_type] => 1 [patent_app_number] => 8/419982 [patent_app_country] => US [patent_app_date] => 1995-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 38 [patent_figures_cnt] => 53 [patent_no_of_words] => 6324 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 148 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004810.pdf [firstpage_image] =>[orig_patent_app_number] => 419982 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/419982
Liver parenchymal cells having clonal growth ability, method for obtaining same, method for subculturing same, and subculturing system of primary hepatocytes Apr 10, 1995 Issued
Array ( [id] => 3814879 [patent_doc_number] => 05789389 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-08-04 [patent_title] => 'BCL2 derived genetic elements associated with sensitivity to chemotherapeutic drugs' [patent_app_type] => 1 [patent_app_number] => 8/405702 [patent_app_country] => US [patent_app_date] => 1995-03-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 14 [patent_figures_cnt] => 14 [patent_no_of_words] => 12787 [patent_no_of_claims] => 4 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 36 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/789/05789389.pdf [firstpage_image] =>[orig_patent_app_number] => 405702 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/405702
BCL2 derived genetic elements associated with sensitivity to chemotherapeutic drugs Mar 16, 1995 Issued
Array ( [id] => 3699145 [patent_doc_number] => 05645991 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-07-08 [patent_title] => 'Transposon-containing DNA cloning vector and uses thereof' [patent_app_type] => 1 [patent_app_number] => 8/403582 [patent_app_country] => US [patent_app_date] => 1995-03-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 5453 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 23 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/645/05645991.pdf [firstpage_image] =>[orig_patent_app_number] => 403582 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/403582
Transposon-containing DNA cloning vector and uses thereof Mar 13, 1995 Issued
Array ( [id] => 3934807 [patent_doc_number] => 05981177 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-11-09 [patent_title] => 'Protein fusion method and constructs' [patent_app_type] => 1 [patent_app_number] => 8/378548 [patent_app_country] => US [patent_app_date] => 1995-01-25 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 16 [patent_figures_cnt] => 14 [patent_no_of_words] => 16340 [patent_no_of_claims] => 19 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 16 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/981/05981177.pdf [firstpage_image] =>[orig_patent_app_number] => 378548 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/378548
Protein fusion method and constructs Jan 24, 1995 Issued
Array ( [id] => 4013862 [patent_doc_number] => 05880102 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-03-09 [patent_title] => 'Adenoviral vector system' [patent_app_type] => 1 [patent_app_number] => 8/374483 [patent_app_country] => US [patent_app_date] => 1995-01-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 108 [patent_figures_cnt] => 113 [patent_no_of_words] => 9281 [patent_no_of_claims] => 36 [patent_no_of_ind_claims] => 13 [patent_words_short_claim] => 7 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/880/05880102.pdf [firstpage_image] =>[orig_patent_app_number] => 374483 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/374483
Adenoviral vector system Jan 16, 1995 Issued
Array ( [id] => 3865933 [patent_doc_number] => 05837484 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1998-11-17 [patent_title] => 'Stable cell lines capable of expressing the adeno-associated virus replication gene' [patent_app_type] => 1 [patent_app_number] => 8/362608 [patent_app_country] => US [patent_app_date] => 1995-01-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 8 [patent_no_of_words] => 7732 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/837/05837484.pdf [firstpage_image] =>[orig_patent_app_number] => 362608 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/362608
Stable cell lines capable of expressing the adeno-associated virus replication gene Jan 8, 1995 Issued
Array ( [id] => 3729666 [patent_doc_number] => 05693533 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1997-12-02 [patent_title] => 'Human breast carcinoma cell line capable of production of a spontaneously metastasizing tumor in animals for use in anticancer drug testing' [patent_app_type] => 1 [patent_app_number] => 8/350938 [patent_app_country] => US [patent_app_date] => 1994-12-07 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2413 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 21 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/693/05693533.pdf [firstpage_image] =>[orig_patent_app_number] => 350938 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/350938
Human breast carcinoma cell line capable of production of a spontaneously metastasizing tumor in animals for use in anticancer drug testing Dec 6, 1994 Issued
Array ( [id] => 4004303 [patent_doc_number] => 06004940 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-12-21 [patent_title] => 'Intracellular targeting of endogenous proteins' [patent_app_type] => 1 [patent_app_number] => 8/350215 [patent_app_country] => US [patent_app_date] => 1994-12-06 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 15 [patent_no_of_words] => 16337 [patent_no_of_claims] => 32 [patent_no_of_ind_claims] => 5 [patent_words_short_claim] => 33 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/004/06004940.pdf [firstpage_image] =>[orig_patent_app_number] => 350215 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/350215
Intracellular targeting of endogenous proteins Dec 5, 1994 Issued
Array ( [id] => 3941146 [patent_doc_number] => 05872225 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 1999-02-16 [patent_title] => 'Method for characterizing the nucleotide sequence of L1CAM and the nucleotide sequence characterized thereby' [patent_app_type] => 1 [patent_app_number] => 8/341843 [patent_app_country] => US [patent_app_date] => 1994-11-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 7 [patent_no_of_words] => 11079 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/05/872/05872225.pdf [firstpage_image] =>[orig_patent_app_number] => 341843 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/341843
Method for characterizing the nucleotide sequence of L1CAM and the nucleotide sequence characterized thereby Nov 17, 1994 Issued
Array ( [id] => 1542299 [patent_doc_number] => 06372502 [patent_country] => US [patent_kind] => B1 [patent_issue_date] => 2002-04-16 [patent_title] => 'Retroviral packaging cell lines and processes of using same' [patent_app_type] => B1 [patent_app_number] => 08/341269 [patent_app_country] => US [patent_app_date] => 1994-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 6472 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 220 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/372/06372502.pdf [firstpage_image] =>[orig_patent_app_number] => 08341269 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/341269
Retroviral packaging cell lines and processes of using same Nov 16, 1994 Issued
08/309026 METHODS FOR GENETICALLY MODIFYING HEMATOPOIETIC STEM CELLS Sep 18, 1994 Abandoned
Array ( [id] => 4268786 [patent_doc_number] => 06245560 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-06-12 [patent_title] => 'Vector with multiple target response elements affecting gene expression' [patent_app_type] => 1 [patent_app_number] => 8/245506 [patent_app_country] => US [patent_app_date] => 1994-05-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 21 [patent_figures_cnt] => 31 [patent_no_of_words] => 11355 [patent_no_of_claims] => 11 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/245/06245560.pdf [firstpage_image] =>[orig_patent_app_number] => 245506 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/245506
Vector with multiple target response elements affecting gene expression May 17, 1994 Issued
Array ( [id] => 4335452 [patent_doc_number] => 06333175 [patent_country] => US [patent_kind] => NA [patent_issue_date] => 2001-12-25 [patent_title] => 'Yield when disulfide-bonded proteins are secreted' [patent_app_type] => 1 [patent_app_number] => 8/097621 [patent_app_country] => US [patent_app_date] => 1993-07-27 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4775 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 79 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/333/06333175.pdf [firstpage_image] =>[orig_patent_app_number] => 097621 [rel_patent_id] =>[rel_patent_doc_number] =>)
08/097621
Yield when disulfide-bonded proteins are secreted Jul 26, 1993 Issued
Menu